Source: mint [India]
“Scientists have developed a vaccine with a new approach called ‘proactive vaccinology,’ which has shown protection in mice against a broad range of coronaviruses with potential for future disease outbreaks, according to a new study published in the journal, ‘Nature Nanotechnology’ on Monday. Under the proactive vaccinology vaccine development process, scientists develop vaccines preemptively, often before the disease-causing pathogen even emerges. The vaccine, ‘Quartet Nanocage,’ developed by Oxford and Caltech, is expected to commence phase one clinical trials in early 2025. However, its intricate design poses manufacturing challenges that may constrain large-scale production. The new vaccine functions by instructing the body’s immune system to identify particular regions of eight distinct coronaviruses, encompassing SARS-CoV-1, SARS-CoV-2, and several strains presently prevalent in bats, which hold the potential to cross over to humans and trigger a pandemic.” (05/08/24)